# Eli Lilly and Company (LLY) — Q4-2016 Earnings Results

**Report date:** 2017-01-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.95 | N/A | -4.04% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management acknowledged the competitive landscape while expressing commitment to advancing their product pipeline. They remain focused on long-term growth despite current pressures.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on innovation and pipeline development.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Eli Lilly's earnings report indicates a slight miss on EPS, reflecting ongoing challenges in the market. Without revenue data or stock reaction details, it's difficult to gauge investor sentiment fully. The management's cautious tone suggests they are aware of the competitive pressures but remain focused on future growth through innovation.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2016_